Life Sciences

GSK settles Paxil suit

Pharma Compliance Alert, October 8, 2008

GlaxoSmithKline (GSK) will pay $40 million to settle a class action lawsuit with 42,000 health plans that covered children and adolescents on Paxil, according to a Minneapolis Star Tribune article.
Physicians treated children and adolescents with Paxil, even though that use is not FDA-approved. The health plans argued GSK withheld information about the safety and effectiveness of Paxil use in children and teens.
GSK already settled another class action lawsuit in 2007. The company agreed to pay consumers $63.9 million. GSK did not admit any wrongdoing in either case.


0 comments on “GSK settles Paxil suit


Most Popular